The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016
Depression is a global health problem associated with a significant public health burden and costs. Although studies on costs of diseases are being considered as an increasingly important factor for health policies, information concerning costs of inpatient care of depression is still insufficient....
Gespeichert in:
| Veröffentlicht in: | PloS one 2018-06, Vol.13 (6), p.e0198890-e0198890 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0198890 |
|---|---|
| container_issue | 6 |
| container_start_page | e0198890 |
| container_title | PloS one |
| container_volume | 13 |
| creator | Zaprutko, Tomasz Göder, Robert Kus, Krzysztof Pałys, Wiktor Rybakowski, Filip Nowakowska, Elżbieta |
| description | Depression is a global health problem associated with a significant public health burden and costs. Although studies on costs of diseases are being considered as an increasingly important factor for health policies, information concerning costs of inpatient care of depression is still insufficient. Thus, the main aim of this study was to evaluate costs of hospitalization of patients treated in 2016 in psychiatric clinics in Poznan (Poland) and in Kiel (Germany) and to analyze treatment used in these centers. The study was conducted from September 2017 to February 2018. 545 hospital records were considered (187 in Poznan and 358 in Kiel). Eventually, 490 hospital records were included, 168 in Poland and 322 in Germany. In general, the costs were calculated based on the patients' sex and diagnosis (F32 and F33) separately and, subsequently, the outcomes were added and multiplied by the length of hospital stay, giving the cost of hospitalization. The annual cost of inpatient care of depression in 2016 was EUR 491,067.19 ([Formula: see text]) in Poznan and EUR 2,847,991.00 [Formula: see text] in Kiel. In Poznan, hospitalization was underfunded reaching EUR 183,042.55 (37.27% of total costs in Poznan). In Poznan, the most frequently prescribed medicine was quetiapine, followed by olanzapine and venlafaxine, whereas in Kiel it was venlafaxine, followed by mirtazapine and promethazine. Although non-pharmacological therapies were commonly used in both centers, in Kiel this type of treatment was better structured. The study confirms the degree of the economic burden of inpatient care of depression. The underfunding of mental health revealed, emphasizes the need for urgent amendment of organization and funding of mental health care in Poland. Patients in Poznan were hospitalized on average 10 days longer than in Kiel, thus a reduction of length of hospitalization in Poznan seems possible. Although pharmacotherapy seemed to be comprehensive in both centers, there were some differences between Poznan and Kiel. Access to non-pharmacological therapies during outpatient care was limited in Poznan, however, compared to Kiel. |
| doi_str_mv | 10.1371/journal.pone.0198890 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2055611198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ae660268b5234b7b9c5b36e7b7c21166</doaj_id><sourcerecordid>2056392159</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-e6b65c734f4db8e02b7a8693d1ceaa624cc27d828d57badda7cdbd217ef920793</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIfsA_QGCJy_awiz9iO74goaqUikr0UM6WPyatV4m92AlS-fUk3bRqERfbmnnzZub5VdU7gjeESfJpm8YcTbfZpQgbTFTTKPyiOiSK0bWgmL188j6ojkrZYsxZI8Tr6oAqhSnl6rAy17eAwKWY-uCQHbOHiFKLQtyZIUAckDMZ5oiHXYZSQopTEl2lP9FEtLpKnYn-BE0H-h6gQ6tzyL2JdyczimIi3lSvWtMVeLvcx9XPr2fXp9_Wlz_OL06_XK4dp2JYg7CCO8nqtva2AUytNI1QzBMHxghaO0elb2jjubTGeyOdt54SCa2iWCp2XH3Y8-66VPSiTtEUcy4ImfSZEBd7hE9mq3c59Cbf6WSCvg-kfKNNHoLrQBsQAlPRWE5ZbaVVjlsmQFrpKCFCTFyfl26j7cG7SalsumekzzMx3Oqb9FsLPP1VPY-7Wghy-jVCGXQfioNukhPSeD-3YIoSPkM__gP9_3b1HuVyKiVD-zgMwXp2zEOVnh2jF8dMZe-fLvJY9GAR9hcqHL29</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2055611198</pqid></control><display><type>article</type><title>The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Zaprutko, Tomasz ; Göder, Robert ; Kus, Krzysztof ; Pałys, Wiktor ; Rybakowski, Filip ; Nowakowska, Elżbieta</creator><creatorcontrib>Zaprutko, Tomasz ; Göder, Robert ; Kus, Krzysztof ; Pałys, Wiktor ; Rybakowski, Filip ; Nowakowska, Elżbieta</creatorcontrib><description>Depression is a global health problem associated with a significant public health burden and costs. Although studies on costs of diseases are being considered as an increasingly important factor for health policies, information concerning costs of inpatient care of depression is still insufficient. Thus, the main aim of this study was to evaluate costs of hospitalization of patients treated in 2016 in psychiatric clinics in Poznan (Poland) and in Kiel (Germany) and to analyze treatment used in these centers. The study was conducted from September 2017 to February 2018. 545 hospital records were considered (187 in Poznan and 358 in Kiel). Eventually, 490 hospital records were included, 168 in Poland and 322 in Germany. In general, the costs were calculated based on the patients' sex and diagnosis (F32 and F33) separately and, subsequently, the outcomes were added and multiplied by the length of hospital stay, giving the cost of hospitalization. The annual cost of inpatient care of depression in 2016 was EUR 491,067.19 ([Formula: see text]) in Poznan and EUR 2,847,991.00 [Formula: see text] in Kiel. In Poznan, hospitalization was underfunded reaching EUR 183,042.55 (37.27% of total costs in Poznan). In Poznan, the most frequently prescribed medicine was quetiapine, followed by olanzapine and venlafaxine, whereas in Kiel it was venlafaxine, followed by mirtazapine and promethazine. Although non-pharmacological therapies were commonly used in both centers, in Kiel this type of treatment was better structured. The study confirms the degree of the economic burden of inpatient care of depression. The underfunding of mental health revealed, emphasizes the need for urgent amendment of organization and funding of mental health care in Poland. Patients in Poznan were hospitalized on average 10 days longer than in Kiel, thus a reduction of length of hospitalization in Poznan seems possible. Although pharmacotherapy seemed to be comprehensive in both centers, there were some differences between Poznan and Kiel. Access to non-pharmacological therapies during outpatient care was limited in Poznan, however, compared to Kiel.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0198890</identifier><identifier>PMID: 29902259</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Cost of Illness ; Costs ; Depression - economics ; Depression - epidemiology ; Depression - therapy ; Diagnostic tests ; Drug therapy ; Employment ; Female ; Germany - epidemiology ; Health care ; Health policy ; Hospitalization - economics ; Hospitals ; Humans ; Inpatients - statistics & numerical data ; Male ; Medicine and Health Sciences ; Mental depression ; Mental disorders ; Mental health ; Middle Aged ; Olanzapine ; Patients ; People and places ; Pharmacoeconomics ; Pharmacology ; Pharmacy ; Poland - epidemiology ; Promethazine ; Psychiatry ; Psychotherapy ; Psychotropic drugs ; Public health ; Quetiapine ; Schizophrenia ; Social Sciences ; Suicides & suicide attempts ; Venlafaxine</subject><ispartof>PloS one, 2018-06, Vol.13 (6), p.e0198890-e0198890</ispartof><rights>2018 Zaprutko et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Zaprutko et al 2018 Zaprutko et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-e6b65c734f4db8e02b7a8693d1ceaa624cc27d828d57badda7cdbd217ef920793</citedby><cites>FETCH-LOGICAL-c526t-e6b65c734f4db8e02b7a8693d1ceaa624cc27d828d57badda7cdbd217ef920793</cites><orcidid>0000-0001-9737-9624</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001949/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001949/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29902259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zaprutko, Tomasz</creatorcontrib><creatorcontrib>Göder, Robert</creatorcontrib><creatorcontrib>Kus, Krzysztof</creatorcontrib><creatorcontrib>Pałys, Wiktor</creatorcontrib><creatorcontrib>Rybakowski, Filip</creatorcontrib><creatorcontrib>Nowakowska, Elżbieta</creatorcontrib><title>The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Depression is a global health problem associated with a significant public health burden and costs. Although studies on costs of diseases are being considered as an increasingly important factor for health policies, information concerning costs of inpatient care of depression is still insufficient. Thus, the main aim of this study was to evaluate costs of hospitalization of patients treated in 2016 in psychiatric clinics in Poznan (Poland) and in Kiel (Germany) and to analyze treatment used in these centers. The study was conducted from September 2017 to February 2018. 545 hospital records were considered (187 in Poznan and 358 in Kiel). Eventually, 490 hospital records were included, 168 in Poland and 322 in Germany. In general, the costs were calculated based on the patients' sex and diagnosis (F32 and F33) separately and, subsequently, the outcomes were added and multiplied by the length of hospital stay, giving the cost of hospitalization. The annual cost of inpatient care of depression in 2016 was EUR 491,067.19 ([Formula: see text]) in Poznan and EUR 2,847,991.00 [Formula: see text] in Kiel. In Poznan, hospitalization was underfunded reaching EUR 183,042.55 (37.27% of total costs in Poznan). In Poznan, the most frequently prescribed medicine was quetiapine, followed by olanzapine and venlafaxine, whereas in Kiel it was venlafaxine, followed by mirtazapine and promethazine. Although non-pharmacological therapies were commonly used in both centers, in Kiel this type of treatment was better structured. The study confirms the degree of the economic burden of inpatient care of depression. The underfunding of mental health revealed, emphasizes the need for urgent amendment of organization and funding of mental health care in Poland. Patients in Poznan were hospitalized on average 10 days longer than in Kiel, thus a reduction of length of hospitalization in Poznan seems possible. Although pharmacotherapy seemed to be comprehensive in both centers, there were some differences between Poznan and Kiel. Access to non-pharmacological therapies during outpatient care was limited in Poznan, however, compared to Kiel.</description><subject>Cost of Illness</subject><subject>Costs</subject><subject>Depression - economics</subject><subject>Depression - epidemiology</subject><subject>Depression - therapy</subject><subject>Diagnostic tests</subject><subject>Drug therapy</subject><subject>Employment</subject><subject>Female</subject><subject>Germany - epidemiology</subject><subject>Health care</subject><subject>Health policy</subject><subject>Hospitalization - economics</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Inpatients - statistics & numerical data</subject><subject>Male</subject><subject>Medicine and Health Sciences</subject><subject>Mental depression</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Middle Aged</subject><subject>Olanzapine</subject><subject>Patients</subject><subject>People and places</subject><subject>Pharmacoeconomics</subject><subject>Pharmacology</subject><subject>Pharmacy</subject><subject>Poland - epidemiology</subject><subject>Promethazine</subject><subject>Psychiatry</subject><subject>Psychotherapy</subject><subject>Psychotropic drugs</subject><subject>Public health</subject><subject>Quetiapine</subject><subject>Schizophrenia</subject><subject>Social Sciences</subject><subject>Suicides & suicide attempts</subject><subject>Venlafaxine</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIfsA_QGCJy_awiz9iO74goaqUikr0UM6WPyatV4m92AlS-fUk3bRqERfbmnnzZub5VdU7gjeESfJpm8YcTbfZpQgbTFTTKPyiOiSK0bWgmL188j6ojkrZYsxZI8Tr6oAqhSnl6rAy17eAwKWY-uCQHbOHiFKLQtyZIUAckDMZ5oiHXYZSQopTEl2lP9FEtLpKnYn-BE0H-h6gQ6tzyL2JdyczimIi3lSvWtMVeLvcx9XPr2fXp9_Wlz_OL06_XK4dp2JYg7CCO8nqtva2AUytNI1QzBMHxghaO0elb2jjubTGeyOdt54SCa2iWCp2XH3Y8-66VPSiTtEUcy4ImfSZEBd7hE9mq3c59Cbf6WSCvg-kfKNNHoLrQBsQAlPRWE5ZbaVVjlsmQFrpKCFCTFyfl26j7cG7SalsumekzzMx3Oqb9FsLPP1VPY-7Wghy-jVCGXQfioNukhPSeD-3YIoSPkM__gP9_3b1HuVyKiVD-zgMwXp2zEOVnh2jF8dMZe-fLvJY9GAR9hcqHL29</recordid><startdate>20180614</startdate><enddate>20180614</enddate><creator>Zaprutko, Tomasz</creator><creator>Göder, Robert</creator><creator>Kus, Krzysztof</creator><creator>Pałys, Wiktor</creator><creator>Rybakowski, Filip</creator><creator>Nowakowska, Elżbieta</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9737-9624</orcidid></search><sort><creationdate>20180614</creationdate><title>The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016</title><author>Zaprutko, Tomasz ; Göder, Robert ; Kus, Krzysztof ; Pałys, Wiktor ; Rybakowski, Filip ; Nowakowska, Elżbieta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-e6b65c734f4db8e02b7a8693d1ceaa624cc27d828d57badda7cdbd217ef920793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cost of Illness</topic><topic>Costs</topic><topic>Depression - economics</topic><topic>Depression - epidemiology</topic><topic>Depression - therapy</topic><topic>Diagnostic tests</topic><topic>Drug therapy</topic><topic>Employment</topic><topic>Female</topic><topic>Germany - epidemiology</topic><topic>Health care</topic><topic>Health policy</topic><topic>Hospitalization - economics</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Inpatients - statistics & numerical data</topic><topic>Male</topic><topic>Medicine and Health Sciences</topic><topic>Mental depression</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Middle Aged</topic><topic>Olanzapine</topic><topic>Patients</topic><topic>People and places</topic><topic>Pharmacoeconomics</topic><topic>Pharmacology</topic><topic>Pharmacy</topic><topic>Poland - epidemiology</topic><topic>Promethazine</topic><topic>Psychiatry</topic><topic>Psychotherapy</topic><topic>Psychotropic drugs</topic><topic>Public health</topic><topic>Quetiapine</topic><topic>Schizophrenia</topic><topic>Social Sciences</topic><topic>Suicides & suicide attempts</topic><topic>Venlafaxine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zaprutko, Tomasz</creatorcontrib><creatorcontrib>Göder, Robert</creatorcontrib><creatorcontrib>Kus, Krzysztof</creatorcontrib><creatorcontrib>Pałys, Wiktor</creatorcontrib><creatorcontrib>Rybakowski, Filip</creatorcontrib><creatorcontrib>Nowakowska, Elżbieta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaprutko, Tomasz</au><au>Göder, Robert</au><au>Kus, Krzysztof</au><au>Pałys, Wiktor</au><au>Rybakowski, Filip</au><au>Nowakowska, Elżbieta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2018-06-14</date><risdate>2018</risdate><volume>13</volume><issue>6</issue><spage>e0198890</spage><epage>e0198890</epage><pages>e0198890-e0198890</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Depression is a global health problem associated with a significant public health burden and costs. Although studies on costs of diseases are being considered as an increasingly important factor for health policies, information concerning costs of inpatient care of depression is still insufficient. Thus, the main aim of this study was to evaluate costs of hospitalization of patients treated in 2016 in psychiatric clinics in Poznan (Poland) and in Kiel (Germany) and to analyze treatment used in these centers. The study was conducted from September 2017 to February 2018. 545 hospital records were considered (187 in Poznan and 358 in Kiel). Eventually, 490 hospital records were included, 168 in Poland and 322 in Germany. In general, the costs were calculated based on the patients' sex and diagnosis (F32 and F33) separately and, subsequently, the outcomes were added and multiplied by the length of hospital stay, giving the cost of hospitalization. The annual cost of inpatient care of depression in 2016 was EUR 491,067.19 ([Formula: see text]) in Poznan and EUR 2,847,991.00 [Formula: see text] in Kiel. In Poznan, hospitalization was underfunded reaching EUR 183,042.55 (37.27% of total costs in Poznan). In Poznan, the most frequently prescribed medicine was quetiapine, followed by olanzapine and venlafaxine, whereas in Kiel it was venlafaxine, followed by mirtazapine and promethazine. Although non-pharmacological therapies were commonly used in both centers, in Kiel this type of treatment was better structured. The study confirms the degree of the economic burden of inpatient care of depression. The underfunding of mental health revealed, emphasizes the need for urgent amendment of organization and funding of mental health care in Poland. Patients in Poznan were hospitalized on average 10 days longer than in Kiel, thus a reduction of length of hospitalization in Poznan seems possible. Although pharmacotherapy seemed to be comprehensive in both centers, there were some differences between Poznan and Kiel. Access to non-pharmacological therapies during outpatient care was limited in Poznan, however, compared to Kiel.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>29902259</pmid><doi>10.1371/journal.pone.0198890</doi><orcidid>https://orcid.org/0000-0001-9737-9624</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2018-06, Vol.13 (6), p.e0198890-e0198890 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2055611198 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | Cost of Illness Costs Depression - economics Depression - epidemiology Depression - therapy Diagnostic tests Drug therapy Employment Female Germany - epidemiology Health care Health policy Hospitalization - economics Hospitals Humans Inpatients - statistics & numerical data Male Medicine and Health Sciences Mental depression Mental disorders Mental health Middle Aged Olanzapine Patients People and places Pharmacoeconomics Pharmacology Pharmacy Poland - epidemiology Promethazine Psychiatry Psychotherapy Psychotropic drugs Public health Quetiapine Schizophrenia Social Sciences Suicides & suicide attempts Venlafaxine |
| title | The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A56%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20economic%20burden%20of%20inpatient%20care%20of%20depression%20in%20Poznan%20(Poland)%20and%20Kiel%20(Germany)%20in%202016&rft.jtitle=PloS%20one&rft.au=Zaprutko,%20Tomasz&rft.date=2018-06-14&rft.volume=13&rft.issue=6&rft.spage=e0198890&rft.epage=e0198890&rft.pages=e0198890-e0198890&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0198890&rft_dat=%3Cproquest_plos_%3E2056392159%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2055611198&rft_id=info:pmid/29902259&rft_doaj_id=oai_doaj_org_article_ae660268b5234b7b9c5b36e7b7c21166&rfr_iscdi=true |